Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.Annals of Neurology|October 7, 2004
Huntington's Disease-like 2 (HDL2) in North America and JapanRussell L Margolis, Susan E Holmes, Adam Rosenblatt, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.Brain : a Journal of Neurology|November 12, 2022
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's diseaseKonstantin Senkevich, Cornelia E Zorca, Aliza Dworkind, et al.Archives of Neurology|September 15, 2010
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease studyRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 14, 2014
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD studyMadeleine E Sharp, Elise Caccappolo, Helen Mejia-Santana, et al.Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.Molecular Neurodegeneration|November 26, 2024
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJace Jones-Tabah, Kathy He, Nathan Karpilovsky, et al.Journal of the International Neuropsychological Society : JINS|November 25, 2010
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD StudyElise Caccappolo, Roy N Alcalay, Helen Mejia-Santana, et al.Pageof 17